|
Volumn 47, Issue 6, 2001, Pages 752-756
|
Results of phase II clinical trial of cycloplatam in refractory solid tumors;Rezul'taty II fazy klinicheskogo izucheniia tsikloplatama pri rezistentnykh solidnykh opukholiiakh.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
CYCLOPLATAM;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
NAVELBINE;
PLATINUM COMPLEX;
PROSTATE SPECIFIC ANTIGEN;
VINBLASTINE;
ADULT;
AGED;
ARTICLE;
BLADDER TUMOR;
BLOOD;
CLINICAL TRIAL;
COMPARATIVE STUDY;
FEMALE;
HUMAN;
MALE;
MESOTHELIOMA;
METASTASIS;
MIDDLE AGED;
MULTICENTER STUDY;
PHASE 2 CLINICAL TRIAL;
PLEURA TUMOR;
PLEURISY;
PROSTATE TUMOR;
TIME;
UTERINE CERVIX TUMOR;
ADULT;
AGED;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DEOXYCYTIDINE;
FEMALE;
HUMANS;
MALE;
MESOTHELIOMA;
MIDDLE AGED;
ORGANOPLATINUM COMPOUNDS;
PLEURAL NEOPLASMS;
PLEURISY;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
TIME FACTORS;
URINARY BLADDER NEOPLASMS;
UTERINE CERVICAL NEOPLASMS;
VINBLASTINE;
|
EID: 0035754763
PISSN: 05073758
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (13)
|
References (0)
|